The Role of Stromal Tumour Infiltrating Lymphocytes (sTIL) Intensity and Programmed Death Ligand 1 () Expression in Breast Cancer Response to Neoadjuvant Therapy in Cipto Mangunkusumo Hospital (CMH), Indonesia

Volume 24, Issue 10, October 2023, Pages 3459-3465

Primariadewi Rustamadji; Devi Felicia; Puspita Eka Wuyung; Tantri Hellyanti

• View Article
• PDF 426.44 K

Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: Correlation between Androgen Receptor Expression and Pathological Response

Volume 21, Issue 2, February 2020, Pages 563-568

Amrallah A Mohammed; Fifi Mostafa Elsayed; Mohammed Algazar; Hayam E Rashed; Abeer Hussien Anter

• View Article
• PDF 476.19 K

Predicting Response to Neoadjuvant Chemotherapy Using 18F FDG PET-CT in Patients with Locally Advanced Breast Cancer

Volume 21, Issue 1, January 2020, Pages 93-98

Narendra Hulikal; Sivanath Reddy Gajjala; Teckchand Kalawat; Silpa Kadiyala; Radhika Kottu

• View Article
• PDF 355.23 K

Response of Triple Negative Breast Cancer to Neoadjuvant Chemotherapy: Correlation between Ki-67 Expression and Pathological Response

Volume 17, Issue 2, February 2016, Pages 807-813

• View Article
• PDF 779.61 K

Predictive Value of IHC4 Score for Pathological Response to Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer

Volume 16, Issue 17, December 2015, Pages 7975-7979

• View Article
• PDF 391.65 K

Expression of Nuclear Factor Kappa B (NF-κB) as a Predictor of Poor Pathologic Response to Chemotherapy in Patients with Locally Advanced Breast Cancer

Volume 15, Issue 2, February 2014, Pages 595-598

• View Article
• PDF 335.94 K